S'abonner

Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa - 27/10/21

Doi : 10.1016/j.pediatrneurol.2021.08.010 
Djamila L. Ghafuri, MD, MPH a, b, 1, Brittany Covert Greene, MPH a, 1, Bilya Musa, BS c, Awwal Gambo, MS c, Abdulrasheed Sani, MIM d, Shehu Abdullahi, MD e, Binta J. Wudil, MBBS c, Halima Bello-Manga, MBBS f, Safiya Gambo, MBBS c, Matin Ghafuri, PharmD a, Holly Cassell, MPH g, Kathleen Neville, MD h, Fenella Kirkham, MD, FRCPCH, Research i, Adetola A. Kassim, MD j, Muktar H. Aliyu, MBBS, DrPH k, Michael R. DeBaun, MD, MPH a, Lori C. Jordan, MD, PhD b,
a Vanderbilt-Meharry Sickle Cell Center for Excellence, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 
b Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University of Medicine, Nashville, Tennessee 
c Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria 
d Department of Pediatrics, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria 
e Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria 
f Department of Hematology and Blood Transfusion, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria 
g Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee 
h Divisions of Pediatric Hematology-Oncology and Clinical Pharmacology and Toxicology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 
i Department of Pediatrics, University of Arkansas for Medical Sciences/Arkansas Children's Hospital, Little Rock, Arkansas 
j Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 
k Health Policy, Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee 

Communications should be addressed to: Jordan; Division of Pediatric Neurology; Department of Pediatrics; 2200 Children's Way 11212; Nashville, TN 37232.Division of Pediatric NeurologyDepartment of Pediatrics2200 Children's Way 11212NashvilleTN37232

Abstract

Background

Nigeria has the highest proportion of children with sickle cell anemia (SCA) globally; an estimated 150,000 infants with SCA are born annually. Primary stroke prevention in children with SCA must include Nigeria. We describe capacity-building strategies in conjunction with two National Institutes of Health–funded primary stroke prevention trials (a feasibility trial and phase III randomized controlled trial) with initial hydroxyurea treatment for children with SCA and abnormal transcranial Doppler (TCD) velocities in Nigeria. We anticipated challenges to conducting clinical trials in a low-resource setting with a local team that had not previously been involved in clinical research and sought a sustainable strategy for primary stroke prevention.

Methods

This is a descriptive, prospective study of challenges, solutions, and research teams in two trials that enrolled a total of 679 children with SCA.

Results

As part of the capacity-building component of the trials, over eight years, 23 research personnel (physicians, nurses, research coordinators, a statistician, and a pharmacist) completed a one-month research governance and ethics training program at Vanderbilt University Medical Center, USA. A lead research coordinator for each site completed the Society of Clinical Research Professionals certification. TCD machines were donated; radiologists and nonradiologists were trained and certified to perform TCD. A scalable E-prescription was implemented to track hydroxyurea treatment. We worked with regional government officials to support ongoing TCD-based screening and funding for hydroxyurea for children with SCA at a high risk of stroke.

Conclusions

Our trials and capacity building demonstrate a sustainable strategy to initiate and maintain pediatric SCA primary stroke prevention programs in Africa.

Le texte complet de cet article est disponible en PDF.

Keywords : Stroke prevention, Low-resource setting, Clinical research, Sickle cell anemia, Global health


Plan


 Funding: Research reported in this publication was supported by the National Institute of Neurological Disorders, United States and Stroke of the National Institutes of Health, United States Grants R21NS080639, R01NS094041, K24-HL147017, Vanderbilt Endowed Chair Funds, and philanthropic awards from the Phillips Family and Afolabi Family. The findings and conclusions in this report are those of the authors and do not necessarily represent the National Institutes of Health's official position.
 Author's Contributions: M.R.D., D.L.G., and L.C.J., had full access to all the data in the study and take responsibility for the integrity of the data and the data analyses' accuracy. The trials were designed by M.R.D, B.C.G., S.A., and L.C.J. The transcranial Doppler training was completed by H.B.-M., A.S., B.J.W., S.G., H.B.-M., S.A., A.S., and K.N.; L.C.J. and F.J.K. verified the strokes with video of neurological examinations; B.C.G. and D.L.G. collected and audited data integrity; M.G. and M.R.D. developed and initiated the e-prescription system at all sites; H.C., B.C.G., H.B.M., A.G., and M.R.D. were responsible for all VIRDE activities; A.A.K., A.G., and S.G. monitored the safety of the participants; B.C.G. and B.J.W. performed the analyses; M.R.D., B.C.G., S.A., L.C.J., and M.H.A. interpreted the results; and D.L.G., B.C.G., A.A.K., L.C.J., and M.R.D. wrote the manuscript. Prior to submission, all authors reviewed the manuscript.
 Consent for Publication: The authors agree to sign a statement attesting authorship, disclosing all potential conflicts of interest, and releasing copyright.
 Competing Interests: The authors declare no competing financial interests.


© 2021  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 125

P. 9-15 - décembre 2021 Retour au numéro
Article précédent Article précédent
  • Disordered Eating Behaviors in Young Individuals With Idiopathic Intracranial Hypertension
  • Itay Tokatly Latzer, Noam Senderowich, Aviva Fattal-Valevski, Alexis Mitelpunkt, Shimrit Uliel-Sibony, Moran Hausman-Kedem
| Article suivant Article suivant
  • Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With Leukodystrophy
  • Francesco Gavazzi, Laura Adang, Amy Waldman, Amanda K. Jan, Geraldine Liu, Scott A. Lorch, Sara B. DeMauro, Justine Shults, Samuel R. Pierce, Elizabeth Ballance, Tracy Kornafel, Ann Harrington, Allan M. Glanzman, Adeline Vanderver

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.